Lawmaker pitches Bill 859 to study and support clinical psychedelic trials in Vermont Sponsor introduced Bill 859 to recreate a psychedelic therapy advisory board and explore joining a multi-state consortium to enable clinical drug development trials (including Ibogaine); members discussed funding, referral to Human Services, and possibly splitting controversial trial provisions from study work.

Vermont is on the brink of exploring groundbreaking psychedelic therapies with Bill 859, aimed at empowering clinical trials for severe depression and PTSD.

Click to read more!

#VT #ClinicalTrials #MentalHealthInnovation #CitizenPortal #RegulatorySafeguards #VermontPsychedelics